Alnylam Pharmaceuticals Inc (ALNY)

02:10 AM

What drives Alnylam Pharmaceuticals Inc. stock priceMarket-crushing stock picks - Autocar Professional

02:10 AM

10:37 AM

Huntington's Disease Clinical, Companies, Therapeutic - openPR.com

10:37 AM

05:15 AM

What analysts say about Alnylam Pharmaceuticals Inc. stockTriple-digit growth rates - Autocar Professional

05:15 AM

Jul 22, 2025

Alnylam Pharmaceuticals Inc. Stock Analysis and ForecastPowerful profit generation - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Alnylam Pharmaceuticals Surges to Top 277 Most Actively Traded Stocks with $412 Million in Trading Volume Following FDA Approval of Patisiran - AInvest

Jul 22, 2025

Jul 22, 2025

Is Alnylam Pharmaceuticals Inc. a good long term investmentHigh-profit capital plays - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Market Sentiment Around Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) - 富途牛牛

Jul 22, 2025

Jul 22, 2025

Alnylam (ALNY) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance

Jul 22, 2025

Jul 21, 2025

10 Most Undervalued Healthcare Stocks To Buy According To Analysts - Insider Monkey

Jul 21, 2025

Jul 21, 2025

Lexicography: Clear And Unequivocal - The National Law Review

Jul 21, 2025

Jul 21, 2025

Lobbying Update: $390,000 of ALNYLAM PHARMACEUTICALS INC. lobbying was just disclosed - Quiver Quantitative

Jul 21, 2025

Jul 21, 2025

Truist Securities initiates Alnylam Pharmaceuticals stock with Buy rating By Investing.com - ca.investing.com

Jul 21, 2025

Jul 21, 2025

This Target Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday - Benzinga

Jul 21, 2025

Jul 21, 2025

This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga

Jul 21, 2025

Jul 19, 2025

Alnylam’s ELEVATE Study: A Closer Look at AHP Treatment and Market Impact - The Globe and Mail

Jul 19, 2025

Jul 18, 2025

Alnylam’s ALN-4324: A Promising Step in Obesity Treatment - TipRanks

Jul 18, 2025

Jul 17, 2025

Alnylam’s HELIOS-A Study: A Promising Update for hATTR Amyloidosis Treatment - TipRanks

Jul 17, 2025

Jul 17, 2025

Alnylam Pharmaceuticals stock price target raised to $290 by Cantor Fitzgerald - Investing.com Canada

Jul 17, 2025

Jul 17, 2025

Health Check: How Prudently Does Alnylam Pharmaceuticals (NASDAQ:ALNY) Use Debt? - Yahoo Finance

Jul 17, 2025

Jul 17, 2025

Alnylam's 2025 Earnings and Strategic Momentum: A Case for Biotech Leadership and Long-Term Value Creation - AInvest

Jul 17, 2025

Jul 17, 2025

Alnylam to Webcast Conference Call Discussing Second Quarter 2025 Financial Results - Business Wire

Jul 17, 2025

Jul 16, 2025

Alnylam’s ConTTRibute Study: A Closer Look at ATTR Amyloidosis Treatment - TipRanks

Jul 16, 2025

Jul 16, 2025

A Glimpse Into The Expert Outlook On Alnylam Pharmaceuticals Through 10 Analysts - Benzinga

Jul 16, 2025

Jul 16, 2025

Amvuttra gains UK approval for heart form of ATTR amyloidosis - The Pharma Letter

Jul 16, 2025

Jul 16, 2025

JPMorgan raises Alnylam Pharmaceuticals stock price target on Amvuttra forecast - Investing.com Canada

Jul 16, 2025

Jul 15, 2025

Hemophilia Clinical Trials, Companies, Therapeutic - openPR.com

Jul 15, 2025

Jul 15, 2025

Alnylam Pharmaceuticals Trading Volume Surges to $289 Million Ranking 356th in Daily Volume - AInvest

Jul 15, 2025

Jul 15, 2025

Alnylam Pharma (ALNY) Receives a Buy from Citi - The Globe and Mail

Jul 15, 2025

Jul 14, 2025

Alnylam Pharmaceuticals Trading Volume Drops 41.67% to $199 Million Ranking 472nd - AInvest

Jul 14, 2025

Jul 14, 2025

Jefferies reiterates Buy rating on Alnylam Pharmaceuticals stock, citing strong Amvuttra sales - Investing.com Canada

Jul 14, 2025

Jul 14, 2025

What makes Alnylam Pharmaceuticals Inc. stock price move sharplyFree Top Growth Stock Recommendations - beatles.ru

Jul 14, 2025

Jul 11, 2025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Alnylam Pharmaceuticals, Inc. (ALNY) - ACCESS Newswire

Jul 11, 2025

Jul 11, 2025

Gene Therapy Market to Hit US$36.55 Billion by 2032 with 19.4% CAGR | MarketsandMarkets™ - Barchart.com

Jul 11, 2025

Jul 11, 2025

Alnylam Pharmaceuticals (ALNY) Target Price Raised by Citigroup | ALNY Stock News - GuruFocus

Jul 11, 2025

Jul 11, 2025

Alnylam (ALNY) Receives Price Target Boost from Citi | ALNY Stoc - GuruFocus

Jul 11, 2025

Jul 07, 2025

Analyst Maintains Buy Rating and Raises PT for ALNY | ALNY Stock News - GuruFocus

Jul 07, 2025

Jul 06, 2025

Alnylam Pharmaceuticals’ SWOT analysis: broad label approval boosts stock outlook - Investing.com

Jul 06, 2025

Jul 04, 2025

BMO Capital Maintains ‘Outperform’ Rating on Alnylam Pharmaceuticals, Inc. (ALNY); Raises PT - MSN

Jul 04, 2025

Jul 02, 2025

Alnylam Beats Acuitas Claim on Patents in Pfizer Shot Suit (1) - Bloomberg Law News

Jul 02, 2025

Jul 01, 2025

Alnylam's Norton site is 'springboard' for expanding manufacturing capacity - The Business Journals

Jul 01, 2025